FindTrial
Sign In

Integrated Multimodal Onco Prehabilitation Programme (IMPROVER) For Overall Recovery Among Post-Surgical Head And Neck Cancer Survivors Receiving chemoradiation therapy In Tertiary Care Center

Integrated Multimodal Onco Prehabilitation Programme (IMPROVER) For Overall Recovery Among Post-Surgical Head And Neck Cancer Survivors Receiving Adjuvant Therapy In Tertiary Care Center- A Randomized Controlled Trial (RCT) - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/087431
Enrollment
84
Registered
2025-05-22
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx

Interventions

Intervention1: IMPROVER programme face to face method: total duration will be till the day of discharge Control Intervention1: IMPROVER programme leaflet: total duration will be till the date of disc

Sponsors

Kusum Ravi Dukan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Adult patients aged above 18 years of either gender with histologically confirmed diagnosis of head and neck cancer. 2.TNM stage III, IV, IVa, IVb planned for surgery 3.Eastern Cooperative Oncology Group (ECOG) score 0 - 2

Exclusion criteria

Exclusion criteria: 1.If any clinical relevance of distant metastases is present. 2.HNC subject having impaired cognitive function. 3.Subject having difficulty completing the exercise intervention due to any severe comorbid conditions. 4.Recurrent cases of head and neck cancer.

Design outcomes

Primary

MeasureTime frame
1 Patient Reported Outcome Measure Information System (PROMIS 29 v2.0)Timepoint: T1 baseline T2 4 weeks T3 Day of discharge—

Secondary

MeasureTime frame
1 EAT-10 scale 2 Maximum Interincisal Opening 3 6MWT Five times sit to stand test 4 Peri and post-surgical comorbidities reported and length of stayTimepoint: T1 Before the surgery T2 4th week T3 Day of discharge—

Countries

India

Contacts

Public ContactDr K Vijaya Kumar

Kasturba Medical College Manglore

vijay.kk@manipal.edu9980189597

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026